Ads
related to: hrtx stock
Search results
Heron Therapeutics (HRTX) Just Flashed Golden Cross Signal: Do You Buy?
Zacks via Yahoo Finance· 4 months agoHeron Therapeutics, Inc. (HRTX) reached a significant support level, and could be a good pick for...
Heron Therapeutics (NASDAQ:HRTX) shareholders have endured a 83% loss from investing in the stock...
Simply Wall St. via Yahoo Finance· 2 years agoHeron Therapeutics, Inc. (NASDAQ:HRTX) shareholders should be happy to see the share price up 12% in...
All You Need to Know About Heron Therapeutics (HRTX) Rating Upgrade to Buy
Zacks via Yahoo Finance· 2 years agoHeron Therapeutics (HRTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism...
How Much Upside is Left in Heron Therapeutics (HRTX)? Wall Street Analysts Think 91%
Zacks via Yahoo Finance· 2 years agoThe average of price targets set by Wall Street analysts indicates a potential upside of 90.6% in...
Will Heron Therapeutics (HRTX) Report Negative Earnings Next Week? What You Should Know
Zacks via Yahoo Finance· 2 days agoHeron Therapeutics (HRTX) doesn't possess the right combination of the two key ingredients for a...
Heron Therapeutics, Inc.'s (NASDAQ:HRTX) recent 11% pullback adds to one-year year losses,...
Simply Wall St. via Yahoo Finance· 9 months agoKey Insights Institutions' substantial holdings in Heron Therapeutics implies that they have...
Investors in Heron Therapeutics (NASDAQ:HRTX) from five years ago are still down 90%, even after 23%...
Simply Wall St. via Yahoo Finance· 3 months agoHeron Therapeutics, Inc. ( NASDAQ:HRTX ) shareholders will doubtless be very grateful to see the...
Heron Therapeutics (HRTX) Reports Q1 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoHeron Therapeutics (HRTX) delivered earnings and revenue surprises of -40% and 6.62%, respectively,...
Heron (HRTX) Gains 19% on FDA Nod for Zynrelef Label Expansion
Zacks via Yahoo Finance· 3 months agoHeron (HRTX) rises 19% on label expansion of its postoperative pain management drug, Zynrelef, to...
Curious about Heron Therapeutics (HRTX) Q4 Performance? Explore Wall Street Estimates for Key...
Zacks via Yahoo Finance· 2 months agoEvaluate the expected performance of Heron Therapeutics (HRTX) for the quarter ended December 2023,...